Noradrenergic Regulation in the BNST
BNST 中的去甲肾上腺素能调节
基本信息
- 批准号:9917488
- 负责人:
- 金额:$ 4.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adrenergic AgentsAdrenergic AgonistsAdrenergic AntagonistsAdrenergic ReceptorAmygdaloid structureArousalAutomobile DrivingAutoreceptorsBehaviorBrainCatecholaminesCell NucleusCellsClinicalCocaineCorticotropin-Releasing HormoneCorticotropin-Releasing Hormone ReceptorsDataEffectivenessElectrophysiology (science)FOS geneFinancial HardshipFundingGlutamatesGuanfacineHealthHumanHypothalamic structureInfusion proceduresLeadLigandsLiteratureLocationMediatingModelingMotivationMusNeuronsNorepinephrineOutcomePainPathway interactionsPharmaceutical PreparationsPlayPopulationProcessPropranololReceptor ActivationReceptor SignalingRegulationRelapseReporterRewardsRodentRoleSignal TransductionSliceSocietiesSourceStressStructure of terminal stria nuclei of preoptic regionSynaptic TransmissionSystemTestingTherapeuticViraladdictionbehavioral responsebeta-adrenergic receptorbrain circuitrycell typecocaine exposurecravingdrug of abuseenhancing factorexperimental studyhyperpolarization-activated cation channelimprovedimproved outcomenew therapeutic targetnoradrenergicnoveloptogeneticspostsynapticpreferenceprophylacticreceptorrecruitresponsesuccesstargeted treatmenttherapeutic candidatetherapeutic developmenttransmission processtreatment strategywithdrawal-induced anxiety
项目摘要
Project Summary
Addiction is a tremendous health and financial burden on our society. A growing literature indicates that
norepinephrine in the brain plays a key role in stress-reward interactions that may mediate key behavioral
responses to drugs of abuse. A previously unappreciated group of noradrenergic neurons in the field of
addiction, cells that project through the ventral noradrenergic bundle (VNAB), are thought to supply the key
norepinephrine. The primary target of the VNAB in the brain is a group of nuclei referred to as the extended
amygdala. In the previous funding periods, we identified actions of each of the major classes of noradrenergic
receptors on excitatory synaptic transmission in the bed nucleus of the stria terminalis, a major component of
the extended amygdala. Moreover, we identified a novel mechanism whereby the noradrenergic system
interacts with the corticotropin releasing factor receptor signaling system to drive recruitment of specific
populations of VTA projecting neurons. We also identified novel actions of alpha2-adrenergic receptors in
regulation of excitatory drive into the BNST.
Adrenergic ligands have been identified as potential prophylactic therapeutic candidates in treating
addiction. While results in human studies have been encouraging, their overall success in improving outcomes
has been modest. We propose that this is in part due to the many disparate actions that the receptors
regulated by these ligands regulate, and that if we could develop a more specific understanding of the
regulated actions that were key to drug-seeking, we could fine tune treatment strategies to increase
effectiveness. Here, we propose experiments to delineate specific pathways through which catecholamine-
CRF signaling interactions regulate stress-induced cocaine seeking, and alpha2-adrenergic receptor-induced
suppression of stress-induced reinstatement.
项目摘要
成瘾对我们的社会来说是一个巨大的健康和经济负担。越来越多的文献表明,
大脑中的去甲肾上腺素在压力-奖励相互作用中起着关键作用,
对滥用药物的反应。肾上腺素能神经元领域中一组以前未被认识到的去甲肾上腺素能神经元
成瘾,通过腹侧去甲肾上腺素能束(VNAB)投射的细胞,被认为提供了关键
去甲肾上腺素VNAB在脑中的主要靶点是一组称为延伸核团的核团。
杏仁核在以前的资助期间,我们确定了每种主要的去甲肾上腺素能受体的作用,
受体对兴奋性突触传递在床核的终纹,一个主要组成部分,
延伸的杏仁核此外,我们发现了一种新的机制,即去甲肾上腺素能系统
与促肾上腺皮质激素释放因子受体信号系统相互作用,
VTA投射神经元的群体。我们还发现了α 2-肾上腺素能受体在脑内的新作用。
调节进入BNST的兴奋性驱动。
肾上腺素能配体已被确定为治疗糖尿病的潜在预防性治疗候选物。
成瘾虽然人类研究的结果令人鼓舞,但它们在改善结果方面的总体成功
一直很谦虚我们认为,这部分是由于受体的许多不同的行动,
如果我们能对这些配体的调节有更具体的了解,
监管行动是寻求毒品的关键,我们可以微调治疗策略,
有效性在这里,我们提出实验来描绘特定的途径,通过它的儿茶酚胺-
CRF信号相互作用调节应激诱导的可卡因寻求和α 2-肾上腺素能受体诱导的
抑制压力诱发的恢复。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANNY G WINDER其他文献
DANNY G WINDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANNY G WINDER', 18)}}的其他基金
BNST GluN2B and CRF signaling in the antidepressant actions of ketamine
BNST GluN2B 和 CRF 信号在氯胺酮抗抑郁作用中的作用
- 批准号:
8717064 - 财政年份:2014
- 资助金额:
$ 4.14万 - 项目类别:
Alcohol action on extended amygdala glutamate synapses
酒精对延长杏仁核谷氨酸突触的作用
- 批准号:
10670471 - 财政年份:2010
- 资助金额:
$ 4.14万 - 项目类别:
Alcohol action on extended amygdala glutamate synapses
酒精对延长杏仁核谷氨酸突触的作用
- 批准号:
10515868 - 财政年份:2010
- 资助金额:
$ 4.14万 - 项目类别:
Alcohol action on extended amygdala glutamate synapses
酒精对延长杏仁核谷氨酸突触的作用
- 批准号:
10685339 - 财政年份:2010
- 资助金额:
$ 4.14万 - 项目类别:
相似海外基金
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
- 批准号:
RGPIN-2014-06641 - 财政年份:2018
- 资助金额:
$ 4.14万 - 项目类别:
Discovery Grants Program - Individual
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
- 批准号:
RGPIN-2014-06641 - 财政年份:2017
- 资助金额:
$ 4.14万 - 项目类别:
Discovery Grants Program - Individual
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
- 批准号:
RGPIN-2014-06641 - 财政年份:2016
- 资助金额:
$ 4.14万 - 项目类别:
Discovery Grants Program - Individual
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
- 批准号:
RGPIN-2014-06641 - 财政年份:2015
- 资助金额:
$ 4.14万 - 项目类别:
Discovery Grants Program - Individual
Development of a new pharmacotherapy for heart failure using alpha-2 adrenergic agonists
使用 α-2 肾上腺素能激动剂开发治疗心力衰竭的新药物疗法
- 批准号:
15K09110 - 财政年份:2015
- 资助金额:
$ 4.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
- 批准号:
RGPIN-2014-06641 - 财政年份:2014
- 资助金额:
$ 4.14万 - 项目类别:
Discovery Grants Program - Individual
Reversing oxidative inhibition of the Na-K pump by beta3 adrenergic agonists: implications for heart failure therapy
β3 肾上腺素能激动剂逆转 Na-K 泵的氧化抑制:对心力衰竭治疗的影响
- 批准号:
nhmrc : 633252 - 财政年份:2010
- 资助金额:
$ 4.14万 - 项目类别:
NHMRC Project Grants
Research of the molecular mechanism in effects of doping drugs(adrenergic agonists)
兴奋剂药物(肾上腺素激动剂)作用的分子机制研究
- 批准号:
21500628 - 财政年份:2009
- 资助金额:
$ 4.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
EFFECTS OF ALPHA2-ADRENERGIC AGONISTS AND NMDA-ANTAGONISTS ON CEREBRAL MICROCIRCULATION UNDER THE HYPOTHERMIC CONDITION -ASSESSED WITH CLOSED CRANIAL WINDOW TECHNIQUE-.
α2-肾上腺素能激动剂和 NMDA 拮抗剂对低温条件下脑微循环的影响 - 用闭颅窗技术评估 -。
- 批准号:
11671489 - 财政年份:1999
- 资助金额:
$ 4.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
EFFECTS OF NMDA-ATAGONISTS AND ALPHA2-ADRENERGIC AGONISTS ON SPINAL AND CEREBRAL MICROCIRCULATION -ASSESSED WITH CLOSED SPINAL AND CRANIAL WINDOW TECHNIQUE-.
NMDA 激动剂和 α2 肾上腺素能激动剂对脊髓和大脑微循环的影响 - 使用闭合脊柱和颅窗技术进行评估 -。
- 批准号:
09671555 - 财政年份:1997
- 资助金额:
$ 4.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




